The core activity of AbbatiaLabs is the development of medical technologies and pharmaceutical products, particularly in the field of personalization of solid dosage forms. The company focuses on the development of drug delivery devices and combination products for various applications, such as diabetes, Parkinson's disease or hormone therapies.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
The oral solid drug primary packaging with titration function, enabling bodyweight-based dosing, dose personalization, reduced dose errors and extended stability for oral medicines.
Co-development of dosing devices and primary packaging
Co-development programs to adapt POWDOSE to a formulation, optimize the dose range and support pharmaceutical partners in personalizing dosing.
Knowledge
No knowledge articles yet
Once AbbatiaLabs SA has claimed this profile, we'll publish editorial articles and case studies here together.